Skip to main content
Top

02-02-2024 | CAR T-Cell Therapy | Podcast | Article

Episode 9

The gut microbiome and CAR T-cell therapy

How do nutrition, supplements and antibiotics impact patient outcomes?

print
PRINT
insite
SEARCH
Guest:
Prof. Marion Subklewe
Host:
Dr. Shreeya Nanda

Recent research suggests that the gut microbiome could be an important modulator of response to CAR T-cell therapy in patients with hematologic cancers.

Prof. Marion Subklewe takes us through the latest evidence, highlighting the impact of antibiotics, nutrition, and dietary supplements, and discusses how to devise interventions to improve patient outcomes.

« Previous episode: AI in stroke

Next episode: Disease-modifying therapy for type 1 diabetes »


print
PRINT

Related topics